Password reset request
  • Portal do Governo Brasileiro
  • Atualize sua Barra de Governo
  • Go to main content [1]
  • Go to main menu [2]
  • Enable hight contrast [3]
English Português Español
  • Sign in
    Forgot my password
> About  >
-
-
-
-
-
 
 

About ReBEC


ReBEC is publicly-owned, managed by the Oswaldo Cruz Foundation, a research organization in government and nonprofit organizations. All details of the studies reported in ReBEC are publicly available. According to resolution of ANVISA - RDC 36, of 27 June 2012 amending RDC 39/2008, all clinical phases I, II, III and IV, must show proof of registration of clinical research in the database Brazilian Registry of Clinical Trials - ReBEC, or proof of submission. For cases prior to publication of this resolution will be accepted proof of registration of the researches that have already been recorded in other primary records of the International Clinical Trials Registration Platform (ICTRP / WHO). For every record there is no cost. The required fields of ReBEC meet the minimum data set required by the International Committee of Medical Journal Editors (ICMJE) and the World Health Organization (WHO). After review and at the time of publication of the study in ReBEC website, the study receives a unique registration number. The responsibility for recording and reporting of studies is the sponsor. The test data will not be removed after they are posted. The result of a joint effort of the Ministry of Health (DECIT/MS), Institute of Communication and Information Science and Technology in Health (Icict/Fiocruz), the Pan American Health Organization (PAHO) and the Latin American and Caribbean Center on Health Sciences (Bireme), the ReBEC increases the effectiveness of efforts to disclose clinical trial studies public way, reducing publication bias. Thus, the ReBEC becomes an important source of information for patients, health professionals, researchers, companies and research centers, providing greater interaction and international integration. Institutional - Coordination Dr. Josue Laguardia
Senior Research Consultant
Dr Luiza Silva Coordinator Fundação Oswaldo Cruz
Instituto de Comunicação e Informação Científica e Tecnológica em Saúde – Icict
Av. Brasil, 4036 - Office Building Expansion - Room 807
Zip Code: 21040-361 - Rio de Janeiro, RJ - Brazil

Phone: +55(21)3882-9227
E-mail: rebec@icict.fiocruz.br
 
Approved trials

09/16/2025
Pancreatic Steatosis in Cystic Fibrosis: Association with CFTR Modulator and Potentiator Therapy, Diabetes, and Bone Density – A Cohort Study in a Multidisciplinary Referral Center
 
09/16/2025
The effect of an intervention on common mental disorders with community health agents
 
09/15/2025
Efficacy of Laser treatment for Onychomycosis: clinical trial
 
09/15/2025
Transcranial Direct Current Stimulation associated with ReST for speech disorders: a randomized clinical trial
 
09/15/2025
How Judo can help boost children's Mental Skills
 
09/15/2025
Effect of desensitizers on the control of dental sensitivity after periodontal treatment
 
09/15/2025
Comparison of cost and quality of life in the treatment of varicose veins by normal surgery and by radiofrequency treatment at Hospital de Américo Brasiliense (SUS)
 

Total de Ensaios Clínicos 16859.

Existem 8293 ensaios clínicos registrados.

Existem 4666 ensaios clínicos recrutando.

Existem 270 ensaios clínicos em análise.

Existem 5738 ensaios clínicos em rascunho.

cadastre um novo usuário

notícias

sobre

ajuda

contato

equipe

links úteis

glossário